新股研究：海普瑞（9989.HK）

Stock Code上市代號 9989.HK IPO Name股份名稱 Shenzhen Hepalink Pharmaceutical Group Co., Ltd. 深圳市海普瑞藥業集團股份有限公司 Offer Price (HK$) 招股價(港元) 18.40 - 20.60 Lot Size (shares) 交易單位(股) 500 No. of Hong Kong Offer Share香港發售股數 22,010,000 No. of Global Offer Share全球發售股數 220,094,500 Sponsor保薦人 Goldman Sachs (Asia) L.L.C., Morgan Stanley Asia Limited Public Application Period招股日期 24 June 2020 (Wed) - 30 June 2020 (Tue) Application Deadline via Kim Eng經金英申請截止日期 29 June 2020 (Mon) 12:00 n.n. Fixed Date定價日期 30 June 2020 (Tue) Announcement Date公佈售股結果日期 7 July 2020 (Tue) Refund Date退款日期 7 July 2020 (Tue) Listing Date上市日期 8 July 2020 (Wed) Prospectus招股書 Shenzhen Hepalink Pharmaceutical Group Co., Ltd. HK$20.60 per Offer Share plus brokerage of 1%, SFC transaction levy of 0.0027% and Stock Exchange trading fee of 0.005% (payable in full on application in Hong Kong dollars and subject to refund) 每股發售股份20.60港元，另加1%經紀佣金、0.0027%證監會交易徵費及0.005%聯交所交易費（須於申請時以港元繳足，多繳股款可根據最終定價予以退還） NUMBER OF PUBLIC OFFER SHARES THAT MAY BE APPLIED FOR AND PAYMENTS 可供申請認購的公開發售股份數目及應繳款項 No. of Public Offer Shares applied for Amount payable on application HK$ No. of Public Offer Shares applied for Amount payable on application HK$ No. of Public Offer Shares applied for Amount payable on application HK$ 申請認購的 公開發售股份數目 申請時應繳款項 港元 申請認購的 公開發售股份數目 申請時應繳款項 港元 申請認購的 公開發售股份數目 申請時應繳款項 港元 500 10,403.80 25,000 520,189.66 800,000 16,646,068.96 1,000 20,807.59 30,000 624,227.59 900,000 18,726,827.58 1,500 31,211.38 35,000 728,265.52 1,000,000 20,807,586.20 2,000 41,615.17 40,000 832,303.45 2,000,000 41,615,172.40 2,500 52,018.97 45,000 936,341.38 3,000,000 62,422,758.60 3,000 62,422.76 50,000 1,040,379.31 4,000,000 83,230,344.80 3,500 72,826.56 60,000 1,248,455.17 5,000,000 104,037,931.00 4,000 83,230.34 70,000 1,456,531.03 6,000,000 124,845,517.20 4,500 93,634.14 80,000 1,664,606.90 7,000,000 145,653,103.40 5,000 104,037.93 90,000 1,872,682.76 8,000,000 166,460,689.60 6,000 124,845.52 100,000 2,080,758.62 9,000,000 187,268,275.80 7,000 145,653.10 200,000 4,161,517.24 10,000,000 208,075,862.00 8,000 166,460.69 300,000 6,242,275.86 11,005,000 228,987,486.13 9,000 187,268.28 400,000 8,323,034.48 10,000 208,075.86 500,000 10,403,793.10 15,000 312,113.79 600,000 12,484,551.72 20,000 416,151.72 700,000 14,565,310.34 DISCLAIMERS: This document is prepared for internal/general circulation and for information purposes only and under no circumstances should it be considered or intended as an offer to sell, to subscribe for or purchase any securities or a solicitation of an offer to buy the securities referred to herein. Information provided in this document is strictly confidential. By accepting this document, you agree to be bound by the terms and limitations set out herein and to keep any information communicated or disclosed in this document in strict confidence. The information contained herein has be